Extended Data Fig. 7: Oncoprint showing mutations in genes in our patient cohorts.
From: Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
Data show no difference in proportion of patients with mutations in the presented genes between patients with high mean HLA-I evolutionary divergence (HED) and low mean HED. LOH = loss of heterozygosity at HLA-I.
